250 related articles for article (PubMed ID: 12885817)
1. Study of the MIB-1 labeling index as a predictor of tumor progression in pilocytic astrocytomas in children and adolescents.
Bowers DC; Gargan L; Kapur P; Reisch JS; Mulne AF; Shapiro KN; Elterman RD; Winick NJ; Margraf LR
J Clin Oncol; 2003 Aug; 21(15):2968-73. PubMed ID: 12885817
[TBL] [Abstract][Full Text] [Related]
2. MIB-1 labeling index in astrocytic tumors--a clinicopathologic study.
Neder L; Colli BO; Machado HR; Carlotti CG; Santos AC; Chimelli L
Clin Neuropathol; 2004; 23(6):262-70. PubMed ID: 15584210
[TBL] [Abstract][Full Text] [Related]
3. Outcome analysis of childhood low-grade astrocytomas.
Fisher PG; Tihan T; Goldthwaite PT; Wharam MD; Carson BS; Weingart JD; Repka MX; Cohen KJ; Burger PC
Pediatr Blood Cancer; 2008 Aug; 51(2):245-50. PubMed ID: 18386785
[TBL] [Abstract][Full Text] [Related]
4. Predictors of tumor progression among children with gangliogliomas. Clinical article.
El Khashab M; Gargan L; Margraf L; Koral K; Nejat F; Swift D; Weprin B; Bowers DC
J Neurosurg Pediatr; 2009 Jun; 3(6):461-6. PubMed ID: 19485728
[TBL] [Abstract][Full Text] [Related]
5. Proliferation index as a predictor of prognosis in malignant gliomas of childhood.
Pollack IF; Campbell JW; Hamilton RL; Martinez AJ; Bozik ME
Cancer; 1997 Feb; 79(4):849-56. PubMed ID: 9024724
[TBL] [Abstract][Full Text] [Related]
6. Diversity of glial cell components in pilocytic astrocytoma.
Tanaka Y; Sasaki A; Ishiuchi S; Nakazato Y
Neuropathology; 2008 Aug; 28(4):399-407. PubMed ID: 18312545
[TBL] [Abstract][Full Text] [Related]
7. Postoperative imaging surveillance in pediatric pilocytic astrocytomas.
Dorward IG; Luo J; Perry A; Gutmann DH; Mansur DB; Rubin JB; Leonard JR
J Neurosurg Pediatr; 2010 Oct; 6(4):346-52. PubMed ID: 20887107
[TBL] [Abstract][Full Text] [Related]
8. Vascularity and angiogenesis as predictors of growth in optic pathway/hypothalamic gliomas.
Bartels U; Hawkins C; Jing M; Ho M; Dirks P; Rutka J; Stephens D; Bouffet E
J Neurosurg; 2006 May; 104(5 Suppl):314-20. PubMed ID: 16848088
[TBL] [Abstract][Full Text] [Related]
9. Proliferative activity as measured by MIB-1 labeling index and long-term outcome of cerebellar juvenile pilocytic astrocytomas.
Roessler K; Bertalanffy A; Jezan H; Ba-Ssalamah A; Slavc I; Czech T; Budka H
J Neurooncol; 2002 Jun; 58(2):141-6. PubMed ID: 12164686
[TBL] [Abstract][Full Text] [Related]
10. Pediatric intracranial ependymomas: prognostic relevance of histological, immunohistochemical, and flow cytometric factors.
Zamecnik J; Snuderl M; Eckschlager T; Chanova M; Hladikova M; Tichy M; Kodet R
Mod Pathol; 2003 Oct; 16(10):980-91. PubMed ID: 14559980
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of Ki-67 labeling indices obtained using MIB-1 monoclonal antibody in patients with supratentorial astrocytomas.
Wakimoto H; Aoyagi M; Nakayama T; Nagashima G; Yamamoto S; Tamaki M; Hirakawa K
Cancer; 1996 Jan; 77(2):373-80. PubMed ID: 8625247
[TBL] [Abstract][Full Text] [Related]
12. The proliferative potential of the pilocytic astrocytoma: the relation between MIB-1 labeling and clinical and neuro-radiological follow-up.
Dirven CM; Koudstaal J; Mooij JJ; Molenaar WM
J Neurooncol; 1998 Mar; 37(1):9-16. PubMed ID: 9525833
[TBL] [Abstract][Full Text] [Related]
13. Predictive factors for early symptomatic recurrence in pilocytic astrocytoma: does angiogenesis have a role to play?
Kurwale NS; Suri V; Suri A; Sarkar C; Gupta DK; Sharma BS; Mahapatra AK
J Clin Neurosci; 2011 Apr; 18(4):472-7. PubMed ID: 21292490
[TBL] [Abstract][Full Text] [Related]
14. Pleomorphic xanthoastrocytoma: what do we really know about it?
Giannini C; Scheithauer BW; Burger PC; Brat DJ; Wollan PC; Lach B; O'Neill BP
Cancer; 1999 May; 85(9):2033-45. PubMed ID: 10223246
[TBL] [Abstract][Full Text] [Related]
15. Tumor recurrence and malignant progression of gangliogliomas.
Majores M; von Lehe M; Fassunke J; Schramm J; Becker AJ; Simon M
Cancer; 2008 Dec; 113(12):3355-63. PubMed ID: 18988291
[TBL] [Abstract][Full Text] [Related]
16. Interobserver reproducibility of MIB-1 labeling index in astrocytic tumors using different counting methods.
Hsu CY; Ho DM; Yang CF; Chiang H
Mod Pathol; 2003 Sep; 16(9):951-7. PubMed ID: 13679460
[TBL] [Abstract][Full Text] [Related]
17. The expression of cell cycle regulatory proteins in oligodendroglial tumors.
Kamiya M; Nakazato Y
Clin Neuropathol; 2002; 21(2):52-65. PubMed ID: 12005253
[TBL] [Abstract][Full Text] [Related]
18. Assessment and prognostic significance of mitotic index using the mitosis marker phospho-histone H3 in low and intermediate-grade infiltrating astrocytomas.
Colman H; Giannini C; Huang L; Gonzalez J; Hess K; Bruner J; Fuller G; Langford L; Pelloski C; Aaron J; Burger P; Aldape K
Am J Surg Pathol; 2006 May; 30(5):657-64. PubMed ID: 16699322
[TBL] [Abstract][Full Text] [Related]
19. Clinico-pathological feature of pilomyxoid astrocytomas: three case reports.
Nagaishi M; Yokoo H; Hirato J; Yoshimoto Y; Nakazato Y
Neuropathology; 2011 Apr; 31(2):152-7. PubMed ID: 20667008
[TBL] [Abstract][Full Text] [Related]
20. Identification of relevant prognostic histopathologic features in 69 intracranial ependymomas, excluding myxopapillary ependymomas and subependymomas.
Kurt E; Zheng PP; Hop WC; van der Weiden M; Bol M; van den Bent MJ; Avezaat CJ; Kros JM
Cancer; 2006 Jan; 106(2):388-95. PubMed ID: 16342252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
